Literature DB >> 27282810

New paradigms in clonal evolution: punctuated equilibrium in cancer.

William Ch Cross1, Trevor A Graham2, Nicholas A Wright2.   

Abstract

Evolutionary theories are themselves subject to evolution. Clonal evolution - the model that describes the initiation and progression of cancer - is entering a period of profound change, brought about largely by technological developments in genome analysis. A flurry of recent publications, using modern mathematical and bioinformatics techniques, have revealed both punctuated and neutral evolution phenomena that are poorly explained by the conventional graduated perspectives. In this review, we propose that a hybrid model, inspired by the evolutionary model of punctuated equilibrium, could better explain these recent observations. We also discuss the conceptual changes and clinical implications of variable evolutionary tempos.
Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  Big Bang; cancer; clonal evolution; colorectal cancer; gradualism; punctuated equilibrium

Mesh:

Year:  2016        PMID: 27282810     DOI: 10.1002/path.4757

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  31 in total

Review 1.  Big Bang Tumor Growth and Clonal Evolution.

Authors:  Ruping Sun; Zheng Hu; Christina Curtis
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  The evolution of tumour phylogenetics: principles and practice.

Authors:  Russell Schwartz; Alejandro A Schäffer
Journal:  Nat Rev Genet       Date:  2017-02-13       Impact factor: 53.242

Review 3.  The Natural History of Colorectal Polyps: Overview of Predictive Static and Dynamic Features.

Authors:  Perry J Pickhardt; Bryan Dustin Pooler; David H Kim; Cesare Hassan; Kristina A Matkowskyj; Richard B Halberg
Journal:  Gastroenterol Clin North Am       Date:  2018-06-29       Impact factor: 3.806

Review 4.  New insights into the earliest stages of colorectal tumorigenesis.

Authors:  Chelsie K Sievers; William M Grady; Richard B Halberg; Perry J Pickhardt
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-05-26       Impact factor: 3.869

5.  Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors.

Authors:  Taku Harada; Eiichiro Yamamoto; Hiro-O Yamano; Hironori Aoki; Hiro-O Matsushita; Kenjiro Yoshikawa; Ryo Takagi; Eiji Harada; Yoshihito Tanaka; Yuko Yoshida; Makoto Eizuka; Akira Yorozu; Gota Sudo; Hiroshi Kitajima; Takeshi Niinuma; Masahiro Kai; Yasushi Sasaki; Takashi Tokino; Tamotsu Sugai; Hiroshi Nakase; Hiromu Suzuki
Journal:  J Gastroenterol       Date:  2018-06-11       Impact factor: 7.527

Review 6.  Evolution of Premalignant Disease.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 7.  Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.

Authors:  William M Grady; Ming Yu
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

Review 8.  The cellular origins of cancer with particular reference to the gastrointestinal tract.

Authors:  Malcolm R Alison
Journal:  Int J Exp Pathol       Date:  2020-08-14       Impact factor: 1.925

9.  Characterization of systemic genomic instability in budding yeast.

Authors:  Nadia M V Sampaio; V P Ajith; Ruth A Watson; Lydia R Heasley; Parijat Chakraborty; Aline Rodrigues-Prause; Ewa P Malc; Piotr A Mieczkowski; Koodali T Nishant; Juan Lucas Argueso
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 11.205

10.  Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.

Authors:  David Fiedler; Kerstin Heselmeyer-Haddad; Daniela Hirsch; Leanora S Hernandez; Irianna Torres; Darawalee Wangsa; Yue Hu; Luis Zapata; Josef Rueschoff; Sebastian Belle; Thomas Ried; Timo Gaiser
Journal:  Int J Cancer       Date:  2018-12-11       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.